CEMPRO.NS(CEMPRO.NS)
CEMPRO.NS
No analyst ratings available
No analyst price targets available for CEMPRO.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $125.11B | $156.38B | $187.11B |
| Low | $117.90B | $140.55B | $171.80B |
| High | $132.85B | $172.94B | $203.26B |
| EBITDA Avg | $6.52B | $8.15B | $9.76B |
| Low | $6.15B | $7.33B | $8.96B |
| High | $6.93B | $9.02B | $10.60B |
| EBIT Avg | $5.48B | $6.85B | $8.19B |
| Low | $5.16B | $6.15B | $7.52B |
| High | $5.82B | $7.57B | $8.90B |
| Net Income Avg | $7.53B | $10.04B | $12.37B |
| Low | $6.83B | $8.58B | $11.06B |
| High | $8.06B | $11.27B | $13.76B |
| EPS Avg | $43.83 | $58.47 | $72.03 |
| Low | $39.76 | $49.97 | $64.37 |
| High | $46.89 | $65.58 | $80.11 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 3 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $28.97B | $32.15B | $36.60B |
| Low | $28.97B | $32.15B | $36.60B |
| High | $28.97B | $32.15B | $36.60B |
| EBITDA Avg | $1.51B | $1.68B | $1.91B |
| Low | $1.51B | $1.68B | $1.91B |
| High | $1.51B | $1.68B | $1.91B |
| EBIT Avg | $1.27B | $1.41B | $1.60B |
| Low | $1.27B | $1.41B | $1.60B |
| High | $1.27B | $1.41B | $1.60B |
| Net Income Avg | $1.61B | $1.96B | $2.42B |
| Low | $1.61B | $1.96B | $2.42B |
| High | $1.61B | $1.96B | $2.42B |
| EPS Avg | $9.40 | $11.40 | $14.10 |
| Low | $9.40 | $11.40 | $14.10 |
| High | $9.40 | $11.40 | $14.10 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |